Literature DB >> 10595733

Chronic active desease refext cancer riski in ulcreative collitis.

M Shinozaki1, T Muto, K Suzuki, K Matsuda, T Yokoyama, T Watanabe, T Masaki, H Sato, S Araki, H Nagawa.   

Abstract

There is an increased risk of developing colorectal neoplasia in ulcerative colitis (UC) and surveillance colonoscopy is recommended for early detection. We investigated the precise features of UC retrospectively to identify a subgroup with longstanding extensive UC at increased risk of neoplasia. From 1985 to August 1997, we experienced eight UC patients with colorectal cancer and eight with definite dysplasia. All 16 had extensive disease of seven years or more in duration. During the same period, 61 of 334 UC patients without colorectal neoplasia were available for detailed study, allowing evaluation of non-surgical patients with extensive colitis of seven years or more in duration. Basic clinical factors including family history of cancer, expressions of disease activity and durations of pharmacotherapy were investigated. Univariate analysis revealed four significant factors: intractability (P=0.001), periods of inflammation persisting for 3 months or more (P<0.01) and total durations of diarrhea (P<0.01) and hematochezia (P<0.05). The number of admissions and the duration of systemic steroid administration were higher in the neoplasia group but without statistical significance. Multivariate analysis revealed two significant factors: duration of diarrhea (P<0.001) and age at onset (P<0.01). Chronic active disease is a risk factor for colorectal cancer or dysplasia in extensive and longstanding UC.

Entities:  

Mesh:

Year:  1999        PMID: 10595733      PMCID: PMC5926007          DOI: 10.1111/j.1349-7006.1999.tb00678.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  20 in total

1.  THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS. III. COMPLICATIONS.

Authors:  F C EDWARDS; S C TRUELOVE
Journal:  Gut       Date:  1964-02       Impact factor: 23.059

2.  Malignancy in ulcerative colitis.

Authors:  N Kvist; O Jacobsen; H K Kvist; P Nørgaard; H H Ockelmann; G Schou; S Jarnum
Journal:  Scand J Gastroenterol       Date:  1989-05       Impact factor: 2.423

Review 3.  Cancer surveillance in ulcerative colitis--a time for reappraisal.

Authors:  A T Axon
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

4.  Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study.

Authors:  D Pinczowski; A Ekbom; J Baron; J Yuen; H O Adami
Journal:  Gastroenterology       Date:  1994-07       Impact factor: 22.682

5.  Cancer surveillance in ulcerative colitis.

Authors:  F W Nugent; R C Haggitt; P A Gilpin
Journal:  Gastroenterology       Date:  1991-05       Impact factor: 22.682

6.  Colon cancer surveillance in chronic ulcerative colitis: historical cohort study.

Authors:  B A Lashner; S V Kane; S B Hanauer
Journal:  Am J Gastroenterol       Date:  1990-09       Impact factor: 10.864

7.  Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. A case-control study.

Authors:  B A Lashner; P A Heidenreich; G L Su; S V Kane; S B Hanauer
Journal:  Gastroenterology       Date:  1989-08       Impact factor: 22.682

8.  Surveillance for colonic carcinoma in ulcerative colitis.

Authors:  E Rosenstock; R G Farmer; R Petras; M V Sivak; G B Rankin; B H Sullivan
Journal:  Gastroenterology       Date:  1985-12       Impact factor: 22.682

Review 9.  Failure of colonoscopic surveillance in ulcerative colitis.

Authors:  D A Lynch; A J Lobo; G M Sobala; M F Dixon; A T Axon
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

10.  Surveillance of patients with chronic ulcerative colitis. WHO Collaborating Centre for the Prevention of Colorectal Cancer.

Authors:  B Levin; J Lennard-Jones; R H Riddell; D Sachar; S J Winawer
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

View more
  1 in total

Review 1.  A Systematic Review and Meta-Analysis on the Association between Inflammatory Bowel Disease Family History and Colorectal Cancer.

Authors:  Hadis Najafimehr; Hamid Asadzadeh Aghdaei; Mohamad Amin Pourhoseingholi; Hamid Mohaghegh Shalmani; Amir Vahedian-Azimi; Matthew Kroh; Mohammad Reza Zali; Amirhossein Sahebkar
Journal:  Gastroenterol Res Pract       Date:  2021-10-23       Impact factor: 2.260

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.